Viewing Study NCT06311656


Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2025-12-30 @ 9:17 AM
Study NCT ID: NCT06311656
Status: COMPLETED
Last Update Posted: 2025-02-24
First Post: 2024-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety, Tolerability of LY4100511 (DC-853) in Healthy Asian and Non-Asian Participants
Sponsor: DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-03-19
Start Date Type: ACTUAL
Primary Completion Date: 2024-10-04
Primary Completion Date Type: ACTUAL
Completion Date: 2024-10-04
Completion Date Type: ACTUAL
First Submit Date: 2024-03-08
First Submit QC Date: None
Study First Post Date: 2024-03-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-02-21
Last Update Post Date: 2025-02-24
Last Update Post Date Type: ACTUAL